Stockscreener 앱 받기
63.93
0.92%
0.58
시간 외 거래:
63.93
Ani Pharmaceuticals Inc 주식(ANIP)의 최신 뉴스
What is ANI Pharmaceuticals Inc. company’s growth strategyExplosive trading opportunities - jammulinksnews.com
What are the latest earnings results for ANI Pharmaceuticals Inc.High-profit trading signals - jammulinksnews.com
How many analysts rate ANI Pharmaceuticals Inc. as a “Buy”Get professional guidance for market timing - jammulinksnews.com
What drives ANI Pharmaceuticals Inc. stock priceUnlock daily trading alerts for profits - jammulinksnews.com
What is the dividend policy of ANI Pharmaceuticals Inc. stockRealize consistent double-digit growth - jammulinksnews.com
How volatile is ANI Pharmaceuticals Inc. stock compared to the marketConsistent wealth multiplication - jammulinksnews.com
ANI Pharmaceuticals Inc. Stock Analysis and ForecastUnlock steady growth with low-risk stocks - jammulinksnews.com
Should I hold or sell ANI Pharmaceuticals Inc. stock in 2025Exceptional profit potential - jammulinksnews.com
What makes ANI Pharmaceuticals Inc. stock price move sharplyAccelerate your capital gains today - jammulinksnews.com
Is ANI Pharmaceuticals Inc. stock overvalued or undervaluedCapitalize on market momentum for maximum profit - jammulinksnews.com
ANI Pharmaceuticals to Discuss Second Quarter 2025 Financial Results on August 8, 2025, at 8:30 a.m. ET - GlobeNewswire
How strong is ANI Pharmaceuticals Inc. company’s balance sheetEntry Signal Tracker For Consistent Profits - jammulinksnews.com
ANI Pharmaceuticals Sets Q2 2025 Earnings Call Date: Key Executive Team to Present Financial Results - Stock Titan
What are ANI Pharmaceuticals Inc. company’s key revenue driversAdvanced Screener Planner For Consistent Profits - jammulinksnews.com
Lacklustre Performance Is Driving ANI Pharmaceuticals, Inc.'s (NASDAQ:ANIP) Low P/S - 富途牛牛
ANI Pharmaceuticals (NASDAQ:ANIP) shareholders are still up 107% over 5 years despite pulling back 4.3% in the past week - simplywall.st
ANI Pharmaceuticals (NASDAQ:ANIP) pulls back 4.3% this week, but still delivers shareholders strong 16% CAGR over 5 years - Yahoo.co
Does ANI Pharmaceuticals Inc. stock perform well during market downturnsEntry Signal Guidance With Proven Results - jammulinksnews.com
Real time scanner hits for ANI Pharmaceuticals Inc. explainedSmart Allocation Stock Pick Insights Gaining Interest - metal.it
ANI Pharmaceuticals Challenges Court Verdict on Royalty Payment Agreement - AInvest
ANI Pharmaceuticals to Challenge Court Verdict - The Globe and Mail
Can ANI Pharmaceuticals Inc. Rally Enough to Break EvenTrend Analysis for Safer Trades Gains Popularity - metal.it
Is ANI Pharmaceuticals Inc. stock poised for growthFast Gaining Stock Screener Reports Released - metal.it
Short Covering May Lift ANI Pharmaceuticals Inc. in Near TermSmart Trade Plans With Risk Protection Explained - metal.it
Why ANI Pharmaceuticals Inc. stock attracts strong analyst attentionTriple Digit Return Forecasts - beatles.ru
CG Oncology wins Delaware jury trial against ANI Pharmaceuticals By Investing.com - Investing.com South Africa
CG Oncology wins Delaware jury trial against ANI Pharmaceuticals - Investing.com Australia
Delaware Superior Court Jury Issues Unanimous Verdict that CG Oncology Owes No Future Royalties or Other Payments to ANI Pharmaceuticals - The Manila Times
CG Oncology Secures Major Legal Victory: Court Rules No 5% Royalties on Promising Bladder Cancer Drug - Stock Titan
Published on: 2025-07-29 19:34:49 - metal.it
Is ANI Pharmaceuticals (ANIP) a High-Probability Earnings Beat Candidate in Q2 2025? - AInvest
ANI Pharmaceuticals (ANIP) Earnings Expected to Grow: What to Know Ahead of Q2 Release - Yahoo Finance
Published on: 2025-07-29 03:23:31 - metal.it
ANI Pharmaceuticals: Classic Case Of Capital Intensive Growth Hampering Value (NASDAQ:ANIP) - Seeking Alpha
How does ANI Pharmaceuticals Inc. compare to its industry peersCapitalize on market shifts before others do - jammulinksnews.com
How does ANI Pharmaceuticals Inc. generate profit in a changing economySkyrocketing returns - jammulinksnews.com
Is ANI Pharmaceuticals Inc. a growth stock or a value stockPhenomenal capital gains - jammulinksnews.com
How ANI Pharmaceuticals Inc. stock performs during market volatility200 Percent Profit Outlook - metal.it
What analysts say about ANI Pharmaceuticals Inc. stockFree Trading Strategy Suggestions - PrintWeekIndia
0.87%
0.80%
자본화:
|
볼륨(24시간):